Cognition Therapeutics, Inc. (CGTX) Financials

CGTX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 38.8 million 9.8 million
2023-06-30 44.0 million 9.6 million
2023-03-31 45.7 million 9.9 million
2022-12-31 50.4 million 10.2 million

CGTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.2 million 1.1 million
2023-06-30 -3.7 million 1.0 million
2023-03-31 -2.7 million 1.2 million
2022-12-31 -10.2 million 902000

CGTX Net Income

No data available :(

CGTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 33.0 million - 735000
2023-06-30 37.2 million - 774000
2023-03-31 38.8 million - 808000
2022-12-31 41.6 million - 844000

CGTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 30.4 million
2023-06-30 29.6 million
2023-03-31 29.1 million
2022-12-31 23.6 million

CGTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 58000 11.7 million 3.1 million -
2023-06-30 18000 8.5 million 3.3 million -
2023-03-31 41000 5.4 million 3.5 million -
2022-12-31 10000 6.4 million 2.9 million -

CGTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 - 65000
2023-06-30 - 61000
2023-03-31 - 60000
2022-12-31 - 60000

CGTX

Price: $1.93

52 week price:
0.90
3.49

Earnings Per Share: -0.86 USD

P/E Ratio: -2.87

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 239600

Market Capitalization: 74.5 million

Links: